An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial

Host Craig Beavers sits down with Kazuhiko Kido, PharmD, a clinical associate professor at the West Virginia University School of Pharmacy, to discuss intravenous iron and its use in patients with heart failure, as well as findings from the FAIR-HF2 clinical trial.

Show notes:

• Anker SD, Friede T, Butler J, et al. Intravenous ferric carboxymaltose in heart failure with iron deficiency. JAMA. 2025;333(22):1965-1976. doi:10.1001/jama.2025.3833
• Kido K, Fang W, Broscious R, et al. Evaluation of a pharmacist-provider collaborative clinic for treatment of iron deficiency in patients with heart failure. Am J Health Syst Pharm. 2023;80(19):1326-1335. doi:10.1093/ajhp/zxad149
• Kido K, Beavers CJ, Dulnuan K, et al. Management of iron deficiency in heart failure: practical considerations and implementation of evidence-based iron supplementation. JACC Heart Fail. 2024;12(12):1961-1978. doi:10.1016/j.jchf.2024.05.014
• Scientific Statement on Diagnosis and Treatment of Iron Deficiency in Heart Failure Released by Heart Failure Society of America. News release. HFSA. May 2, 2023. Accessed June 27, 2025.
• Antrim A. Enhancing Patient Care in Heart Failure-Related Anemia Through Improved Communication, Monitoring, and Education. Pharmacy Times. March 17, 2025. Accessed June 27, 2025.